Document is current
Any future updates will be listed below
-
Authors
Reimer, Jens
Vogelmann, Tobias
Trümper, Daniel
Scherbaum, Norbert
-
Funding
Funding for this research was provided by:
Indivior
- License Information
-
More Information
Article History
Received: 24 May 2019
Accepted: 11 December 2019
First Online: 16 December 2019
Ethics approval and consent to participate
: This study was based on previously available and fully anonymized data and did not involve any new studies of human or animal subjects performed by any of the authors. Therefore, no ethics review and approval or informed consent for participants was required. However, approvals from the involved SHIs were obtained to use their data for this study.
: Not applicable.
: Jens Reimer reports personal fees from Indivior, during the conduct of the study; personal fees from Sanofi-Aventis, personal fees from Hexal, grants and personal fees from Mundipharma, personal fees from Camurus, grants and personal fees from Indivior, outside the submitted work.Norbert Scherbaum reports personal fees from Sanofi-Aventis, personal fees from Indivior, personal fees from AbbVie, personal fees from MSD Pharma, personal fees from Mundipharma, during the conduct of the study.Tobias Vogelmann reports personal fees from Indivior, during the conduct of the study; personal fees from Indivior, outside the submitted work.Daniel Trümper reports personal fees from Indivior.
